When: Confirmed 10-EMA reclaim with volume

Then: Add 50% position

HOLD

• MACD histogram accelerated from negative 0.29 to negative 1.51 in three sessions, representing a regime change rather than routine pullback
• Four independent technical signals converging bearish: 10-EMA break, VWMA break, bearish engulfing at highs, Bollinger midline loss
• 200-SMA intact at $313.60, but using long-term trend as justification to ignore short-term breakdown is an anchoring error
• ROE at 17.8% generating returns on a $5.0 trillion balance sheet faces different capital requirements than on a $4.0 trillion balance sheet
• Trading at 2.64 times book with bank multiples historically compressing in adverse regimes
• Net debt up 243% year over year; trading securities up 120% since 2022 (duration risk concentration)
• JPMorgan's own strategists publicly warning about credibility risk in Treasury policy and term premium expansion
• NII guidance raise to $105.5 billion already reflected in 14 times forward earnings multiple
• Aggressive analyst's upside target of $400-$430 assumes 50-SMA holds with no contingency if it doesn't
• Q2 earnings contained approximately $4.4 billion in unusual items that may not recur
• Current price at $351.55; next structural support at 200-SMA ($313.60), representing 11% downside
• 86% no-cut probability is a known catalyst already priced into current multiple
• Stop-loss placement at $342 above entry at $340 is a structural flaw that would trigger immediately on any upward movement

→ vs aggressive: The 'healthy pullback in bull market' framing is unfalsifiable - anything that recovers gets labeled that in hindsight, anything that doesn't becomes 'unforeseen'. The aggressive analyst treats one possible outcome as the only outcome.

→ vs aggressive: The Gordon Growth model assumes stable inputs. ROE of 17.8% on a $5.0 trillion balance sheet requires more capital and higher returns to justify cost of equity than on a smaller base. The question is whether the market will pay 2.64 times book when the macro environment is shifting, not whether current ROE justifies current multiples.

→ vs aggressive: Net debt up 243% year over year cannot be dismissed as 'operational scaling.' Trading securities up 120% since 2022 represents duration risk concentration in a bond market that JPMorgan's own analysts are warning about - this is not core lending growth.

→ vs aggressive: Tom Lee/Fundstrat endorsements are sentiment inputs with a track record of being right sometimes and very wrong other times; flow impact lasts weeks, not quarters. NII guidance of $105.5 billion is already priced into the 14 times forward multiple - buying because a known catalyst exists means paying full price for already-monetized optionality.

→ vs aggressive: The aggressive analyst's 2.5-to-1 reward-to-risk ratio only holds if the 50-SMA holds. If it fails on a closing basis, the next support is the 200-SMA at $313.60 (11% below current), and in a stress regime JPM can trade meaningfully below that level. The risk-reward calculation has no acknowledgment of what happens if the moving average doesn't hold.

HOLD for existing positions; scaled entry approach for new positions with corrected stop-loss placement

• Normalized earnings power of $17.78 billion after stripping unusual items is a record
• ROE of 17.8% justifies a meaningful multiple premium
• MACD histogram accelerated from negative 0.29 to negative 1.51 in three sessions
• 10-EMA broke, VWMA broke on volume, and bearish engulfing at highs - coordinated technical breakdown signal
• 50-SMA at 342 as key support/invalidation level on closing basis
• Scaled entry approach: 25% at current ~351, 25% on 50-SMA hold at 342 with reversal candle, 50% on confirmed reclaim of 10-EMA at 358 with volume
• Stop-loss correction required: below 340 (335-337) for entry at 340; below 340 or 342 for entry at 345
• Net debt up 243% year-over-year; trading securities up 120% since 2022
• 86% no-cut probability is bullish for NII structurally
• 8% recession odds - credit costs should remain benign near-term
• 2.64x P/B with 17.8% ROE is quality-adjusted fair value, not stretched
• NII guidance raise to 105.5 billion is recent issued guidance not fully priced in
• Support cluster at 325 to 330, representing 6-8% downside from current levels
• Invalidation level: close below 50-SMA on rising volume at 342

→ vs aggressive: Being intellectually dishonest about technical breakdown - MACD accelerated from negative 0.29 to negative 1.51, VWMA broke on volume, and bearish engulfing at highs cannot be dismissed as short-term froth digesting; price targets of 400-430 claim asymmetric reward-to-risk but upside is year-out contingent while downside is near-term stop that could trigger tomorrow; entry at 351 with $9 risk window to 342 stop is overconfidence, not conviction

→ vs conservative: Overstating leverage risk - net debt and trading securities increases are part of market-making operations, hedge accounting, and liquidity provision at a major dealer, not reckless duration risk; conflating research opinion with actual balance sheet risk concentration; waiting for full technical confirmation means entry at 355-358 when risk-reward is already reduced